Zobrazeno 1 - 10
of 485
pro vyhledávání: '"H Landen"'
Publikováno v:
Citováno v: Kuchař, Karel: Mapová sbírka B.P. Molla, s. 267
Citováno v: IKAR
Citováno v: IKAR
Externí odkaz:
http://www.manuscriptorium.com/apps/index.php?direct=record&pid=MZK___-MZKB__MOLL0090900A1F0004A-xx
Autor:
Krisanits, Bradley A.1,2 (AUTHOR) bradley.krisanits@vcuhealth.org, Kaur, Bhoomika1,2 (AUTHOR) bhoomika.kaur7@gmail.com, Fahey, Jed W.3,4 (AUTHOR) jfahey@jhmi.edu, Turner, David P.1,2 (AUTHOR) david.turner1@vcuhealth.org
Publikováno v:
Molecules. Dec2024, Vol. 29 Issue 24, p5986. 17p.
Autor:
Damri, Odeya1 (AUTHOR) odeyad@post.bgu.ac.il, Agam, Galila1 (AUTHOR) galila@bgu.ac.il
Publikováno v:
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13277. 10p.
Publikováno v:
International Journal of Clinical Practice. 61:1509-1515
Summary Aim and methods: Data were collected from 3814 patients in this postmarketing surveillance study to assess the efficacy and tolerability of moxifloxacin. Results: Improvement was observed in 69.1% of the patients after 3 days of moxifloxacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e08f7d8999483a8fee87e676bf2fcca
https://doi.org/10.1111/j.1742-1241.2007.01484.x
https://doi.org/10.1111/j.1742-1241.2007.01484.x
Publikováno v:
Clinical Drug Investigation. 26:733-744
Objective: To compare the real-life treatment of acute exacerbations of chronic bronchitis (AECBs) using moxifloxacin tablets or one of the oral macrolides azithromycin, clarithromycin or roxithromycin in terms of symptom relief, time until improveme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0dbf0064d537ba59634cd36070b8c8a
https://doi.org/10.2165/00044011-200626120-00007
https://doi.org/10.2165/00044011-200626120-00007
Publikováno v:
Journal of International Medical Research. 33:337-348
We assessed the safety, efficacy and patient acceptability of vardenafil (Levitra®, Bayer HealthCare, Leverkusen, Germany) under real-life conditions in patients with erectile dysfunction (ED) in a multinational post-marketing surveillance study. An
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb6aee9bea9bd14119a6c491ebfc086
https://doi.org/10.1177/147323000503300309
https://doi.org/10.1177/147323000503300309
Publikováno v:
Clinical Drug Investigation. 25:691-700
Objective: This study aimed to investigate the efficacy, safety and tolerability of sequential intravenous (IV)/oral therapy with moxifloxacin in pneumonia under general hospital treatment conditions. Patients and methods: Patients with pneumonia wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7500c2db706b7cbfa8384456cd421b
https://doi.org/10.2165/00044011-200525110-00002
https://doi.org/10.2165/00044011-200525110-00002
Publikováno v:
Fortschritte der Neurologie · Psychiatrie. 72:397-403
The objective of this phase IV surveillance study was to document the efficacy and tolerability of flupenthixol as well as the quality of life of patients suffering from schizophrenia and to gain insights into which doses were actually used in specia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73aef4e06936c9c78aa14553352b908e
https://doi.org/10.1055/s-2004-818386
https://doi.org/10.1055/s-2004-818386
Publikováno v:
International Journal of Antimicrobial Agents. 23:35-40
This post-marketing surveillance study including 3859 hospitalised patients with urinary tract infection (UTI) was conducted to evaluate the efficacy and tolerability of treatment with intravenous or orally administered ciprofloxacin. The most freque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec47b2b78d00b97498cc8bbce1d48cee
https://doi.org/10.1016/j.ijantimicag.2003.09.010
https://doi.org/10.1016/j.ijantimicag.2003.09.010
Publikováno v:
Nervenheilkunde. 22:365-368
ZusammenfassungIn einer Postmarketing-Studie konnten 899 Patientinnen und Patienten mit Migräne bis zu 3 konsekutive Migräneattacken mit Almotriptan (12,5 mg) behandeln. Dokumentiert wurden so 2131 behandelte Migräneattacken. Eine Wirkung nach 2 S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65e3e7e4614f6835c8ec55228c8c00fd
https://doi.org/10.1055/s-0038-1626310
https://doi.org/10.1055/s-0038-1626310